Trials / Sponsors / Glenn J. Hanna
Glenn J. Hanna
Academic / Other · 7 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Toripalimab With Chemotherapy for Sinus Cancer Sinonasal Cancer, Paranasal Sinus Neoplasms, Squamous Cell Carcinoma | Phase 2 | 2025-06-17 |
| Recruiting | A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers Salivary Gland Cancer, Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Cancer | Phase 2 | 2025-02-26 |
| Recruiting | Phase II Study of RP2 as Immunoprevention in High-Risk Oral Precancerous Disease High-Risk Oral Precancerous Disease | Phase 2 | 2025-01-01 |
| Recruiting | PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Cancer | Phase 2 | 2024-02-16 |
| Recruiting | CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma | Phase 1 / Phase 2 | 2023-06-01 |
| Completed | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head and Neck Cancer | Phase 2 | 2021-10-14 |
| Active Not Recruiting | 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer | Phase 2 | 2021-09-14 |